Synonym/Acronym
Lower limb venography, phlebography, venogram.
Rationale
To visualize and assess the venous vasculature in the lower extremities related to diagnosis of deep vein thrombosis (DVT) and congenital anomalies.
Patient Preparation
There are no activity restrictions unless by medical direction. Instruct the patient to fast and restrict fluids for 8 hr, or as ordered, prior to the procedure. Fasting may be ordered as a precaution against aspiration related to possible nausea and vomiting. The American Society of Anesthesiologists has fasting guidelines for risk levels according to patient status. More information can be located at www.asahq.org.
Note: Protocols regarding the use of iodinated contrast medium in patients with impaired kidney function and who are receiving metformin or drugs containing metformin for type 2 diabetes may vary by facility; the drug may be discontinued on the day of the test and continue to be withheld for 48 hr after the test. Kidney function should be assessed per facility protocol before use of metformin is resumed (e.g., Cr, eGFR, hydration or clinical assessment).
Regarding the patients risk for bleeding, the patient should be instructed to avoid taking natural products and medications with known anticoagulant, antiplatelet, or thrombolytic properties or to reduce dosage, as ordered, prior to the procedure. Number of days to withhold medication is dependent on the type of anticoagulant. Note the last time and dose of medication taken. Protocols may vary among facilities.
Normal Findings
No obstruction to flow and no filling defects after injection of radiopaque contrast medium; steady opacification of superficial and deep vasculature with no filling defects.
Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.
Study type: X-ray, Special/Contrast; related body system: .
Venography allows x-ray visualization of the venous vasculature system of the extremities after injection of an iodinated contrast medium. Lower extremity studies identify and locate thrombi within the venous system of the lower limbs. After injection of the contrast medium, x-ray images are taken at timed intervals. Usually both extremities are studied, and the unaffected side is used for comparison with the side suspected of having DVT or other venous abnormalities, such as congenital malformations or incompetent valves. Thrombus formation usually occurs in the deep calf veins and at the venous junction and its valves. If DVT is not treated, it can lead to femoral and iliac venous occlusion, or the thrombus can become an embolus, causing a pulmonary embolism. Venography is accurate for identifying thrombi in veins below the knee. Noninvasive diagnostic imaging technologies (e.g., computed tomography [CT], magnetic resonance imaging [MRI], duplex ultrasound [US]) have replaced angiographic venography to a large extent.
Contraindications
Pregnancy is a general contraindication to procedures involving radiation.
Patients with conditions associated with adverse reactions to contrast medium (e.g., asthma, food allergies, or allergy to contrast medium). Although patients are asked specifically if they have a known allergy to iodine or shellfish (shellfish contain high levels of iodine), it has been well established that the reaction is not to iodine; an actual iodine allergy would be problematic because iodine is required for the production of thyroid hormones. In the case of shellfish, the reaction is to a muscle protein called tropomyosin; in the case of iodinated contrast medium, the reaction is to the noniodinated part of the contrast molecule. Patients with a known hypersensitivity to the medium may benefit from premedication with corticosteroids and diphenhydramine; the use of nonionic contrast or an alternative noncontrast imaging study, if available, may be considered for patients who have severe asthma or who have experienced moderate to severe reactions to ionic contrast medium.
Patients with moderate to marked renal impairment (glomerular filtration rate less than 30 mL/min/1.73 m2), or with conditions associated with preexisting renal insufficiency (e.g., chronic kidney disease, single kidney transplant, nephrectomy, diabetes, multiple myeloma, treatment with aminoglycosides and NSAIDs), because iodinated contrast is nephrotoxic.
Patients with moderate to marked renal impairment (glomerular filtration rate less than 30 mL/min/1.73 m2) and who are also taking metformin, which may put them at risk for development of drug-induced lactic acidosis, a dangerous and sometimes fatal adverse effect of metformin (related to renal impairment that does not support sufficient excretion of metformin).
Patients who are chronically dehydrated before the test, especially older adults and patients whose health is already compromised, because of their risk of contrast-induced acute kidney injury.
Patients with bleeding disorders, because the puncture site may not stop bleeding.
Patients with severe edema of the legs in whom venous access is not possible.
Factors That May Alter the Results of the Study
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
Procedural Information
Potential Nursing Actions
Make sure a written and informed consent has been signed prior to the procedure and before administering any medications.
Safety Considerations
After the Study: Implementation & Evaluation Potential Nursing Actions
Avoiding Complications
Treatment Considerations
Clinical Judgement
Follow-Up and Desired Outcomes